Neural Regeneration Research ›› 2016, Vol. 11 ›› Issue (8): 1230-1231.doi: 10.4103/1673-5374.189173
Previous Articles
Next Articles
Cell-specifc mineralocorticoid receptors: future therapeutic targets for stroke?
Quynh N. Dinh, Grant R. Drummond, Christopher G. Sobey, Sophocles Chrissobolis*
- Vascular Biology & Immunopharmacology Group, Cardiovascular Disease Program and Department of Pharmacology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia (Dinh QN, Drummond GR, Sobey CG)
Department of Pharmaceutical and Biomedical Sciences, Raabe College of Pharmacy, Ohio Northern University, Ada, OH, USA (Chrissobolis S)
-
Online:2016-08-31
Published:2016-08-31
-
Contact:
Sophocles Chrissobolis, Ph.D., s-chrissobolis@onu.edu.
-
-
Supported by:We wish to acknowledge the many researchers who have contributed to the work on aldosterone and the mineralocorticoid receptor in cardiovascular disease whose work could not be cited due to the restriction on the number of references. Author’s work cited in this article was supported by a postdoctoral fellowship from the National Health and Medical Research Council (NHMRC) of Australia, and the Foundation for
High Blood Pressure Research Australia (to SC), and grants from the NHMRC and the National Heart Foundation of Australia. CGS and GRD are Senior Research Fellows of the NHMRC.
